After discussing private health insurance exchanges yesterday, today we look into a few recent issues on the public exchanges.
A brief Accenture report describes the rapid growth in private health insurance exchanges and the factors behind that growth.
Studies in the Journal of the American Medical Association look at the evidence behind FDA approval of new drugs and at the reasons for delay or denials of approval.
A brief from the Kaiser Family Foundation looks at out-of-pocket spending by Medicare Beneficiaries, including premiums and service cost-sharing. For some seniors, these numbers are pretty large.
The Government Accounting Office reviews drug spending for DOD, Medicare and Medicaid; finding that Medicaid generally paid the lowest prices, in some cases substantially lower.
Keeping guidelines consistent with the latest scientific evidence may not be happening as consistently as it should be, according to research in the Journal of the American Medical Association.
A report from the Massachusetts Association of Health Plans summarizes what has been learned in the state about its ongoing growth in health spending.
The latest issue of Health Affairs focuses on “big data” and analytics, but the content reflects how little this latest hot initiative has actually achieved.
Research published in Health Affairs explores the question of whether the now-widespread use of electronic medical records is facilitating upcoding by hospitals, leading to higher Medicare reimbursements.
To understand changes in the number of insured following implementation of the reform law, it would be useful to know who comprised this group, a task undertaken by an AHRQ Statistical Brief.